13 Nov 2017

Provisional suspension imposed on Spencer Furman


Spencer Furman has been provisionally suspended under Article 8.3.1(c) of the 2017 Tennis Anti-Doping Programme (the "Programme"), pending determination of the charge against him at a full hearing pursuant to Article 8 of the Programme.

Mr. Furman, an unranked 21-year-old player from the United States of America, provided a urine sample on 9 September 2017 in association with his participation in the Qualifying Draw of the Atlantic Tire Championships, an ATP Challenger, held in Cary, NC, USA. The sample was sent to the World Anti-Doping Agency (“WADA”) accredited laboratory in Montreal, Canada for analysis, and was found to contain d-amphetamine.

D-amphetamine is a Non-Specified substance, which is prohibited under category S6(a) of the 2017 WADA Prohibited List (Stimulants), and therefore is also prohibited under the Programme. Positive tests for Non-Specified Substances carry a mandatory Provisional Suspension.

On 3 November 2017, Mr. Furman was charged with an Anti-Doping Rule Violation under Article 2.1 of the Programme (presence of a Prohibited Substance in a Player’s Sample), and was Provisionally Suspended with effect from 13 November 2017. Mr. Furman had (and retains) the right to apply to the Chair of the Independent Tribunal convened to hear his case why the Provisional Suspension should not be imposed, but chose not to exercise that right.